Ryan Weispfenning | VP-Investor Relations |
Omar Ishrak | Chairman and CEO |
Karen Parkhill | CFO |
Michael Coyle | EVP and Group President of Cardiac and Vascular Group |
Robert White | EVP and President of Minimally Invasive Therapies Group |
Geoffrey Martha | EVP and President of Restorative Therapies Group |
David Lewis | Morgan Stanley |
Bob Hopkins | Bank of America |
Robert Marcus | JPMorgan |
Larry Biegelsen | Wells Fargo |
Vijay Kumar | Evercore ISI |
Matthew Taylor | UBS |
Josh Jennings | Cowen |
Credit Suisse | Credit Suisse |
Matthew O'Brien | Piper Jaffray |
Danielle Antalffy | SVB Leerink |
Raj Denhoy | Jefferies |
Ladies and gentlemen, thank you for standing by. And welcome to the Medtronic Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.